Skip to main content
NCBI home page
The BMJ logoLink to The BMJ
. 1992 Jul 4;305(6844):5–6. doi: 10.1136/bmj.305.6844.5

Ecstasy and the dance of death.

J A Henry
PMCID: PMC1882471  PMID: 1353390

Full text

PDF
5

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Benazzi F., Mazzoli M. Psychiatric illness associated with "ecstasy". Lancet. 1991 Dec 14;338(8781):1520–1520. doi: 10.1016/0140-6736(91)92332-v. [DOI] [PubMed] [Google Scholar]
  2. Climko R. P., Roehrich H., Sweeney D. R., Al-Razi J. Ecstacy: a review of MDMA and MDA. Int J Psychiatry Med. 1986;16(4):359–372. doi: 10.2190/dcrp-u22m-aumd-d84h. [DOI] [PubMed] [Google Scholar]
  3. Creighton F. J., Black D. L., Hyde C. E. 'Ecstasy' psychosis and flashbacks. Br J Psychiatry. 1991 Nov;159:713–715. doi: 10.1192/bjp.159.5.713. [DOI] [PubMed] [Google Scholar]
  4. Gordon C. J., Watkinson W. P., O'Callaghan J. P., Miller D. B. Effects of 3,4-methylenedioxymethamphetamine on autonomic thermoregulatory responses of the rat. Pharmacol Biochem Behav. 1991 Feb;38(2):339–344. doi: 10.1016/0091-3057(91)90288-d. [DOI] [PubMed] [Google Scholar]
  5. Greer G., Tolbert R. Subjective reports of the effects of MDMA in a clinical setting. J Psychoactive Drugs. 1986 Oct-Dec;18(4):319–327. doi: 10.1080/02791072.1986.10472364. [DOI] [PubMed] [Google Scholar]
  6. McGuire P., Fahy T. Chronic paranoid psychosis after misuse of MDMA ("ecstasy") BMJ. 1991 Mar 23;302(6778):697–697. doi: 10.1136/bmj.302.6778.697. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. McKenna D. J., Peroutka S. J. Neurochemistry and neurotoxicity of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). J Neurochem. 1990 Jan;54(1):14–22. doi: 10.1111/j.1471-4159.1990.tb13277.x. [DOI] [PubMed] [Google Scholar]
  8. Peroutka S. J., Newman H., Harris H. Subjective effects of 3,4-methylenedioxymethamphetamine in recreational users. Neuropsychopharmacology. 1988 Dec;1(4):273–277. [PubMed] [Google Scholar]
  9. Ricaurte G., Bryan G., Strauss L., Seiden L., Schuster C. Hallucinogenic amphetamine selectively destroys brain serotonin nerve terminals. Science. 1985 Sep 6;229(4717):986–988. doi: 10.1126/science.4023719. [DOI] [PubMed] [Google Scholar]
  10. Schifano F. Chronic atypical psychosis associated with MDMA ("ecstasy") abuse. Lancet. 1991 Nov 23;338(8778):1335–1335. doi: 10.1016/0140-6736(91)92633-d. [DOI] [PubMed] [Google Scholar]
  11. Screaton G. R., Singer M., Cairns H. S., Thrasher A., Sarner M., Cohen S. L. Hyperpyrexia and rhabdomyolysis after MDMA ("ecstasy") abuse. Lancet. 1992 Mar 14;339(8794):677–678. doi: 10.1016/0140-6736(92)90834-p. [DOI] [PubMed] [Google Scholar]
  12. Whitaker-Azmitia P. M., Aronson T. A. "Ecstasy" (MDMA)-induced panic. Am J Psychiatry. 1989 Jan;146(1):119–119. doi: 10.1176/ajp.146.1.119b. [DOI] [PubMed] [Google Scholar]
  13. Winstock A. R. Chronic paranoid psychosis after misuse of MDMA. BMJ. 1991 May 11;302(6785):1150–1151. doi: 10.1136/bmj.302.6785.1150-b. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES